期刊文献+

美托洛尔联合丹参注射液治疗乙型肝炎肝硬化性心肌病的临床研究 被引量:4

A clinical study of metoprolol with salviae miltiorrhizae treatment on cirrhotic cardiomyopathy resulting from Hepatitis B
下载PDF
导出
摘要 目的观察美托洛尔联合丹参对乙型肝炎肝硬化性心肌病(CCM)的治疗作用。方法将84例CCM患者随机分为A组、B组、C组和D组,每组均21例,A组采用常规治疗,B组采用常规治疗+美托洛尔治疗,C组采用常规治疗+丹参治疗,D组采用常规治疗+美托洛尔+丹参治疗,疗程4周,检测肝功能,以彩色多普勒超声测定左室射血分数(LVEF)及舒张早期/晚期最大血流速度(E峰/A峰,E/A)比值。结果 A组肝功能指标好转,与治疗前比较差异无显著性(P>0.05)。LVEF、E/A比值与治疗前比较差异无显著性(P>0.05)。B组肝功能指标好转,与治疗前比较差异无显著性(P>0.05),E/A比值与治疗前比较差异有显著性(P<0.01),C组肝功能指标好转,与治疗前比较差异有显著性(P<0.01),LVEF,E/A比值与治疗前比较差异无显著性(P>0.05)。D组患者肝功能指标好转和LVEF、E/A比值上升程度无论1周、2周和4周明显优于A组、B组和C组(P<0.01)。结论美托洛尔联合丹参对CCM有较好的治疗作用。 [ Objective ] To explore the effects of Metoprolol with Salviae mihiorrhizae in treatment of patients with Cirrhotic Cardiomyopathy (CCM) Resuhing from Hepatitis B. [Methods] A total of 84 patients with CCM were randomly divided into group A(n =21) treated with routine method and group B(n =21) treated with Metoprolol and rou- tine method. Group C(n =21) were treated with Salviae mihiorrhizae and routine method. Group D(n =21) were treated with Metoprolol, Salviae miltiorrhizae and routine method. Treated for four weeks. The value of left venhicular ejection fraction (LVED and the ratio of early diastolic/late peak velocity(E/A) were measured by color Doppler. [ Resuits ] The liver function in group A was not significantly improved compared with those before treatment (P 〉0.05), while the levels of LVEF and the ratio of E/A were not significantly improved compared with those before treatment (P 〉0.05). The liver function in group B was not significantly improved compared with those before treatment (P 〉 0.05), while the levels of LVEF and the ratio of E/A were significantly higher compared with those before treatment(P〈0.01). The liver function in group C was significantly improved compared with those before treatment (P 〉0.05). While the levels of LVEF and the ratio of E/A were not significantly improved compared with those before treatment (P 〉0.05). The liver function, LVEF, and the ratio of E/A in group D were significantly higher compared with those of group A, B and group C(P 〈0.01). [ Conclusion] The results suggested that Metoprolol with Salviae miltiorrhizae can play a therapeutic role in CCM.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第33期65-68,共4页 China Journal of Modern Medicine
关键词 美托洛尔 丹参 乙型肝炎 肝硬化性心肌病 Metoprolol salviae miltiorrhizae hepatitis type B cirthotic cardiomyopathy
  • 相关文献

参考文献5

二级参考文献200

共引文献87

同被引文献44

  • 1周永香,范修才.36例乙型肝炎病人病毒核糖核酸、肌钙蛋白Ⅰ与心电图改变关系的探讨[J].中国临床医学,2005,12(1):74-76. 被引量:4
  • 2吴立群,万学发,刘骏.病毒性肝炎患者合并心脏并发症及心肌酶谱变化[J].中国微生态学杂志,2005,17(4):306-306. 被引量:2
  • 3Jian-Gao Fan,Geoffrey C. Farrell.Epidemiology of non-alcoholic fatty liver disease in China[J].Journal of Hepatology.2008(1)
  • 4Merceds Susan Mandell,Mei-Yung Tsou.Cardiovascular Dysfunction in Patients with End-stage Liver Disease[J].Journal of the Chinese Medical Association.2008(7)
  • 5Leon A. Adams,James F. Lymp,Jenny St. Sauver,Schuyler O. Sanderson,Keith D. Lindor,Ariel Feldstein,Paul Angulo.The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study[J].Gastroenterology.2005(1)
  • 6Roberto Latini,Serge Masson,Noeleen de Angelis,Inder Anand.Role of brain natriuretic peptide in the diagnosis and management of heart failure: Current concepts[J].Journal of Cardiac Failure.2002(5)
  • 7Krag A,Bendtsen F, Henriksen JH, et al. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites [J]. Gut, 2010, 59 ( 1 ) : 105-110.
  • 8Moller S,Henriksen J H.Cirrhotic cardiomyopathy[J].Journal of Hepatology,2010,53(11):179-190.
  • 9Enrico M,Antonio A,Domenico M.Cirrhotic cardiomyopathy[J].Journal of the American College of Cardiology,2010,7(56):539-549.
  • 10Palazzuoli A,Gallotta M,Quatrini I,et al.Natriuretic peptides(BNP and NT-pro BNP):measurement and relevance in heart failure.[J]Vascular Health and Risk Management,2010,6(7):411-418.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部